Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats (Q48432702)

11 February 2018

title

Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats (English)

1 reference

11 February 2018

0 references

1 reference

Adrie W Bruijnzeel

1 reference

11 February 2018

George Zislis

series ordinal

1 reference

11 February 2018

Carrie Wilson

series ordinal

1 reference

11 February 2018

Mark S Gold

series ordinal

1 reference

11 February 2018

language of work or name

English

0 references

publication date

30 August 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

1 reference

11 February 2018

issue

1 reference

11 February 2018

page(s)

955-963

1 reference

11 February 2018

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nornicotine is self-administered intravenously by rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Psychostimulant withdrawal as an inducing condition in animal models of depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Severe deficit in brain reward function associated with fentanyl withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nicotine maintains robust self-administration in rats on a limited-access schedule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Nicotine self-administration in rats on a progressive ratio schedule of reinforcement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin-releasing factor, norepinephrine, and stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Opponent Process Model and Psychostimulant Addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Plasticity of reward neurocircuitry and the 'dark side' of drug addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Corticotropin‐Releasing Factor Stimulates Catecholamine Release in Hypothalamus and Prefrontal Cortex in Freely Moving Rats as Assessed by Microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Rodent model of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Decreased brain reward produced by ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Modulation by corticotropin-releasing factor of monoamine metabolism in the lateral hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

The scientific case that nicotine is addictive.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Blockade of nicotine self-administration with nicotinic antagonists in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301192

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301192

1 reference

11 February 2018

1 reference

11 February 2018